New Delhi [India], May 15 (ANI): A total of 1,559 COVID-19 patients are in the Intensive Care Units (ICU) across the country as of Friday afternoon out of the total confirmed cases in the country.
New Delhi [India], May 15 (ANI): The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the treatment of COVID-19 patients.
Washington D.C. [US], May 14 (ANI): Those on the frontline in the battle against coronavirus are expressing "glimmers of hope" as far as the treatment of COVID-19 patients is concerned.
Lucknow (Uttar Pradesh) [India], May 13 (ANI): After the approval is granted by the Ethical Committee to the guidelines sent from the Department of AYUSH, treatment with Ayurvedic medicines will be started in King George's Medical University (KGMU).
Raipur (Chhattisgarh) [India], May 13 (ANI): One more COVID-19 patient from Kabirdham was cured and discharged by AIIMS Raipur on Wednesday. With this, the total count of active cases in the hospital is now at four, said Chief Minister Bhupesh Baghel.
Raipur (Chhattisgarh) [India], May 13 (ANI): One more COVID-19 patient in the state has been cured and discharged from the All India Institute Of Medical Sciences, Raipur on Wednesday, informed hospital administration.
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Mumbai (Maharashtra) [India], May 13 (ANI): Multiple hospitals which come under the Brihanmumbai Municipal Corporation (BMC) have started using a new drug to treat patients who have been severely affected due to COVID-19.
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
New Delhi [India], May 12 (ANI): In a record time of just 36 days a non-invasive BiPAP Ventilator 'SwasthVayu' has been developed by CSIR - National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat COVID-19 patients.
New Delhi [India], May 11 (ANI): As India's COVID-19 count surges to 67,152, Union Health Ministry on Monday issued a revised discharge policy for COIVD-19 patients under which a person having mild infection can be discharged after 10 days of symptom onset and if there is no fever for thr